8-K: ATI Physical Therapy Secures $26 Million in Convertible Note Financing

ATI Physical Therapy finalized a $26 million convertible note financing to bolster its financial position.

Summary

• ATI Physical Therapy closed a $26 million financing on March 3, 2025, through the issuance of 8% second lien PIK convertible notes.
• The notes, issued to existing preferred equity holders, will mature on August 24, 2028.
• Interest is payable quarterly in-kind, increasing the principal balance.
• The financing aims to strengthen ATI's financial foundation and support its strategic objectives.
• Additional details are available in the company's Form 8-K filing with the SEC.

Sentiment

Score: 4

Explanation: While the financing is presented as a positive step, the document acknowledges significant risks and uncertainties, including concerns about the company's ability to continue as a going concern. The delisting from the NYSE and trading on the OTC Pink Sheets further contribute to a negative sentiment.

Positives

• The $26 million financing provides ATI with additional capital.
• The financing is viewed by management as a critical step in fortifying the company's financial foundation.

Negatives

• The company's liquidity position raises substantial doubt about its ability to continue as a going concern.
• The company's common stock was delisted from the NYSE on December 3, 2024, and currently trades on the OTC Pink Sheets.

Risks

• The company's liquidity position raises substantial doubt about its ability to continue as a going concern.
• The company faces risks associated with liquidity and capital markets, including its ability to generate sufficient cash flows.
• The company's ability to meet financial covenants as required by its Credit Agreement, as amended, is a risk.
• The company is subject to risks related to outstanding indebtedness and preferred stock, rising interest rates and potential increases in borrowing costs.
• The company's dependence upon governmental and third-party private payors for reimbursement is a risk.
• The company faces risks associated with public health crises, epidemics and pandemics and their direct and indirect impacts or lingering effects on the business.
• The company's inability to compete effectively in a competitive industry, subject to rapid technological change and cost inflation, is a risk.
• The company faces risks associated with trading on the OTC Pink Sheets, including liquidity constraints and limited regulatory oversight.

Future Outlook

The company intends, promptly after the date hereof, to deregister and suspend, as applicable, the shares of Common Stock from the reporting requirements of Section 12(g) and Section 15(d) of the Securities Exchange Act of 1934, as amended.

Management Comments

• Sharon Vitti, Chief Executive Officer, stated that the new financing is a critical step in fortifying the company's financial foundation and positioning it to execute on its strategic vision.

Industry Context

The announcement reflects the ongoing challenges and strategic adjustments within the outpatient physical therapy sector, where companies are navigating reimbursement pressures, competition, and evolving patient care models.

Related Party Transactions

• The new second lien PIK convertible notes were issued to certain of its existing preferred equity holders.

Stakeholder Impact

• Shareholders may experience dilution due to the potential conversion of the notes into common stock.
• Employees face uncertainty due to the company's financial challenges and potential impact on operations.
• Customers may be affected by any changes in service quality or clinic locations resulting from the company's financial situation.
• Suppliers and creditors face increased risk due to the company's financial instability.

Next Steps

• The company intends to deregister and suspend the shares of Common Stock from the reporting requirements of Section 12(g) and Section 15(d) of the Securities Exchange Act of 1934, as amended.

Key Dates